The genetic and biochemical basis of human leading strand synthesis
Abstract
Abstract The maintenance of genome stability requires efficient leading strand synthesis by DNA Polymerase Epsilon (Polε). By performing CRISPR genetic screens in cells lacking the POLE4 subunit of Polε we define a genetic map of the factors required to support Polε function in the absence of its accessory subunits. A set of genes involved in iron metabolism emerge as required to sustain Iron Sulphur Cluster (ISC)-dependent Polε activity. We then dissect a synthetic lethal interaction between POLE3-POLE4 and the CHTF18-RFC2/5 complex. By combining cell biology, structural modelling and biochemistry, we define the existence of two tiers of regulation of Polε processivity: leading strand-specific loading of PCNA by CHTF18-RFC2/5 and “gripping” of newly synthesised dsDNA by POLE3-POLE4. The combined loss of these functions is incompatible with leading strand synthesis and viability. In summary, we describe the biochemical basis of human leading strand synthesis and the consequence of its dysfunction in genome stability.
Article Details
Authors (12)
Alessandro Agnarelli
Lauryn Buckley-Benbow
Meryem Ozgencil
Melanie Lad
Cancer Research Horizons, Joint AstraZeneca-Cancer Research Horizons Functional Genomics Centre
Khamal Kwesi Ampah
Alex Kalinka
Ondrej Belan
Sarah Maslen
Mark J. Skehel
David Walter
Cancer Research Horizons, Joint AstraZeneca-Cancer Research Horizons Functional Genomics Centre
Matthew Day
Roberto Bellelli